Bernards Rene 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Oct 4, 2023
Insider Transaction Report
Form 4
Bernards Rene
Director
Transactions
- Purchase
Common Stock
2023-10-03$2.51/sh+5,527$13,873 - Purchase
Common Stock
2023-10-02$2.29/sh+4,473$10,243
Footnotes (2)
- [F1]The Reporting Person acquired an aggregate of 4,473 shares in numerous trades at prices ranging from $2.29-$2.40
- [F2]The Reporting Person acquired an aggregate of 5,527 shares in numerous trades ranging from $2.51-$2.58